Literature DB >> 3571218

Equilibrium ligand binding to the human erythrocyte sugar transporter. Evidence for two sugar-binding sites per carrier.

A L Helgerson, A Carruthers.   

Abstract

Equilibrium [3H]cytochalasin B binding to class I sites of human red cell membranes (the sugar transporter) was examined in the presence and absence of intracellular or extracellular sugars known to interact with the transport system. D-Glucose, a transported sugar, is without effect on cytochalasin B binding when present in the extracellular medium but is an effective inhibitor of binding when present within the cell. Ethylidene glucose and maltose (reactive but nontransported sugars) inhibit cytochalasin B (CCB) binding when present either outside or inside the red cell. Inhibition by intracellular sugar (Si) is of the simple, linear competitive type. Inhibition by extracellular sugars (So) is more complex; the Kd(app) for cytochalasin B binding increases in a saturable fashion with [So]. These observations are compared with the predictions of the one-site, alternating conformer model and the two-site model for substrate binding to the sugar transporter, X. The experimental results are inconsistent with the one-site model but are explained by a two-site model in which the ternary complexes of So . X . Si or So . X . CCBi exist and where the binding sites for So and Si display negative cooperativity when occupied by nontransported substrate and little or no cooperativity when occupied by the transported species, D-glucose.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3571218

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  28 in total

Review 1.  Will the original glucose transporter isoform please stand up!

Authors:  Anthony Carruthers; Julie DeZutter; Amit Ganguly; Sherin U Devaskar
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-08-18       Impact factor: 4.310

2.  Kinetic Basis of Cis- and Trans-Allostery in GLUT1-Mediated Sugar Transport.

Authors:  Kenneth P Lloyd; Ogooluwa A Ojelabi; Andrew H Simon; Julie K De Zutter; Anthony Carruthers
Journal:  J Membr Biol       Date:  2017-12-05       Impact factor: 1.843

3.  Proteolytic dissection as a probe of conformational changes in the human erythrocyte glucose transport protein.

Authors:  A F Gibbs; D Chapman; S A Baldwin
Journal:  Biochem J       Date:  1988-12-01       Impact factor: 3.857

4.  Exofacial photolabelling of the human erythrocyte glucose transporter with an azitrifluoroethylbenzoyl-substituted bismannose.

Authors:  A E Clark; G D Holman
Journal:  Biochem J       Date:  1990-08-01       Impact factor: 3.857

5.  Functional expression of mammalian glucose transporters in Xenopus laevis oocytes: evidence for cell-dependent insulin sensitivity.

Authors:  J C Vera; O M Rosen
Journal:  Mol Cell Biol       Date:  1989-10       Impact factor: 4.272

6.  Initial steps of alpha- and beta-D-glucose binding to intact red cell membrane.

Authors:  A Janoshazi; A K Solomon
Journal:  J Membr Biol       Date:  1993-03       Impact factor: 1.843

7.  Substrate specificity and kinetic parameters of GLUT3 in rat cerebellar granule neurons.

Authors:  F Maher; T M Davies-Hill; I A Simpson
Journal:  Biochem J       Date:  1996-05-01       Impact factor: 3.857

8.  Predicting the three-dimensional structure of the human facilitative glucose transporter glut1 by a novel evolutionary homology strategy: insights on the molecular mechanism of substrate migration, and binding sites for glucose and inhibitory molecules.

Authors:  Alexis Salas-Burgos; Pavel Iserovich; Felipe Zuniga; Juan Carlos Vera; Jorge Fischbarg
Journal:  Biophys J       Date:  2004-08-23       Impact factor: 4.033

9.  alpha- and beta-monosaccharide transport in human erythrocytes.

Authors:  Jeffry M Leitch; Anthony Carruthers
Journal:  Am J Physiol Cell Physiol       Date:  2008-11-05       Impact factor: 4.249

10.  Dynamic modulation of intracellular glucose imaged in single cells using a FRET-based glucose nanosensor.

Authors:  Scott A John; Michela Ottolia; James N Weiss; Bernard Ribalet
Journal:  Pflugers Arch       Date:  2007-12-11       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.